Please ensure Javascript is enabled for purposes of website accessibility

OrganiGram Announces a New At-The-Market Share Sale Program

By Eric Volkman – Apr 22, 2020 at 4:09PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The cannabis company is going back to the stock market for fresh capital.

OrganiGram Holdings (OGI -0.46%) is laying the foundation for a new round of capital raising. The Canadian cannabis company announced Wednesday morning that it has established a new at-the-market stock program.

Under it, OrganiGram will sell up to 49 million Canadian dollars ($34.5 million) worth of stock on either or both of the two main exchanges on which it's listed: the NASDAQ and the Toronto Stock Exchange.

If it used the full authorization, that would amount to selling almost 23 million shares at the current stock price. According to the most recent data on Yahoo Finance, the marijuana company currently has slightly over 173 million U.S. shares outstanding.

Marijuana buds atop scattered U.S. currency.

Image source: Getty Images.

In a press release, OrganiGram said that the monies raised by the stock sales will be utilized for capital expenditures, debt retirement, and "general corporate purposes." It did not get more specific. 

Secondary share issues are fairly commonplace in the cannabis industry since companies within it are frequently unprofitable and struggle with cash flow issues. OrganiGram is no exception: It now has more than three times as many shares outstanding than it did in the mid-2010s. This fresh share issue is sure to stoke concern about shareholder dilution, which has been a major worry for investors in the publicly traded cannabis space for quite some time. 

Investors didn't seem to be taking news of the at-the-market program especially well. In early afternoon trading on Wednesday, OrganiGram's shares closed the day down by 1.9%, in contrast to the gains recorded by the major stock market indexes.


Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

OrganiGram Holdings Stock Quote
OrganiGram Holdings
$0.90 (-0.46%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.